GlobeNewsWire · GLP · October 12, 2026

Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor Agonist

Get the app for more

Explore stock news, insights and company research.